Vimarsana
Biggest News Aggregation in the World

Page 3 - Card Fail News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Card Fail. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Card Fail Today - Breaking & Trending Today

CORVIA MEDICAL CLOSES $54 MILLION FINANCING TO SUPPORT PLANNED CONFIRMATORY TRIAL OF THE CORVIA® ATRIAL SHUNT - Vimarsana News

CORVIA MEDICAL CLOSES $54 MILLION FINANCING TO SUPPORT PLANNED CONFIRMATORY TRIAL OF THE CORVIA® ATRIAL SHUNT

Published: June 9, 2022

/PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure (HF), today announced the closing of a $54 million...

Source: prnewswire.com
Related Topics:
Lisa EnszEdwards LifesciencesPaul LavioletteGlobal Public Health Burden Of Heart FailureCorvia Medical IncCorvia Atrial ShuntBoard ChairmanCorvia MedicalBreakthrough DeviceThird Rock VenturesGeneral Catalyst PartnersLumira VenturesPulmonary Vascular Disease May AlterTherapeutic Atrial Shunt DevicePublic Health BurdenCard Fail
Corvia Medical, Inc.: REDUCE LAP-HF II ANALYSES SHOW 50% OF STUDY PATIENTS DEMONSTRATED SIGNIFICANT CLINICAL BENEFIT FROM THE CORVIA ATRIAL SHUNT - Vimarsana News

Corvia Medical, Inc.: REDUCE LAP-HF II ANALYSES SHOW 50% OF STUDY PATIENTS DEMONSTRATED SIGNIFICANT CLINICAL BENEFIT FROM THE CORVIA ATRIAL SHUNT

Published: April 1, 2022

Landmark trial advances understanding of which HFpEF patients may benefit from atrial shunt therapy TEWKSBURY, Mass., April 1, 2022 /PRNewswire/ -- Corvia Medical, Inc, a company

Source: finanznachrichten.de
Related Topics:
Lisa EnszKostenloser WertpapierhandelJan KomtebeddeSanjiv ShahDavid KayeEdwards LifesciencesBaker InstituteDepartment Of CardiologyYork Heart AssociationCorvia Medical IncGlobal Public Health Burden Of Heart FailurePrnewswire Corvia Medical IncCirculatory Failure Research At Mayo ClinicResearch For The Bluhm Cardiovascular InstituteHead Of Heart Failure ResearchCorvia Atrial ShuntBluhm Cardiovascular InstituteNorthwestern University Feinberg SchoolCirculatory Failure ResearchMayo ClinicKansas City Cardiomyopathy QuestionnaireNew York Heart AssociationAlfred HospitalHeart Failure ResearchSenior Vice President
REDUCE LAP-HF II ANALYSES SHOW 50% OF STUDY PATIENTS DEMONSTRATED SIGNIFICANT CLINICAL BENEFIT FROM THE CORVIA® ATRIAL SHUNT - Vimarsana News

REDUCE LAP-HF II ANALYSES SHOW 50% OF STUDY PATIENTS DEMONSTRATED SIGNIFICANT CLINICAL BENEFIT FROM THE CORVIA® ATRIAL SHUNT

Published: April 1, 2022

/PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure (HF), announced publication of analyses from its...

Source: prnewswire.com
Related Topics:
Jan KomtebeddeDavid KayeEdwards LifesciencesBaker InstituteCirculatory Failure Research At Mayo ClinicDepartment Of CardiologyYork Heart AssociationCorvia Medical IncGlobal Public Health Burden Of Heart FailureHead Of Heart Failure ResearchCorvia Atrial ShuntCirculatory Failure ResearchMayo ClinicKansas City Cardiomyopathy QuestionnaireNew York Heart AssociationAlfred HospitalHeart Failure ResearchSenior Vice PresidentCorvia MedicalBreakthrough DeviceThird Rock VenturesGeneral Catalyst PartnersLumira VenturesPulmonary Vascular Disease May AlterTherapeutic Atrial Shunt Device
Corvia Medical, Inc.: LANDMARK REDUCE LAP-HF II TRIAL DEMONSTRATES CLINICAL BENEFIT OF CORVIA ATRIAL SHUNT IN LARGE SEGMENT OF HEART FAILURE PATIENTS - Vimarsana News

Corvia Medical, Inc.: LANDMARK REDUCE LAP-HF II TRIAL DEMONSTRATES CLINICAL BENEFIT OF CORVIA ATRIAL SHUNT IN LARGE SEGMENT OF HEART FAILURE PATIENTS

Published: February 1, 2022

REDUCE LAP-HF II study defines treatable HFpEF patient population for atrial shunt therapy TEWKSBURY, Mass., Feb. 1, 2022 /PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming

Source: finanznachrichten.de
Related Topics:
United StatesGeorge FazioLisa EnszKostenloser WertpapierhandelJan KomtebeddeSanjiv ShahEdwards LifesciencesCorvia Medical IncGlobal Public Health Burden Of Heart FailurePrnewswire Corvia Medical IncCirculatory Failure Research At Mayo ClinicEuropean UnionBaim InstituteResearch For The Bluhm Cardiovascular InstituteCorvia Atrial ShuntHeart Failure TherapeuticsBluhm Cardiovascular InstituteNorthwestern University Feinberg SchoolKansas City Cardiomyopathy QuestionnaireBarry BorlaugCirculatory Failure ResearchMartin LeonInterventional Cardiovascular CareColumbia University Irving Medical CenterSenior Vice President
LANDMARK REDUCE LAP-HF II TRIAL DEMONSTRATES CLINICAL BENEFIT OF CORVIA® ATRIAL SHUNT IN LARGE SEGMENT OF HEART FAILURE PATIENTS - Vimarsana News

LANDMARK REDUCE LAP-HF II TRIAL DEMONSTRATES CLINICAL BENEFIT OF CORVIA® ATRIAL SHUNT IN LARGE SEGMENT OF HEART FAILURE PATIENTS

Published: February 1, 2022

/PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure (HF), today announced results from its REDUCE LAP-HF II...

Source: prnewswire.com
Related Topics:
United StatesGeorge FazioLisa EnszJan KomtebeddeEdwards LifesciencesCirculatory Failure Research At Mayo ClinicCorvia Medical IncGlobal Public Health Burden Of Heart FailureEuropean UnionBaim InstituteKansas City Cardiomyopathy QuestionnaireBarry BorlaugCirculatory Failure ResearchCorvia Atrial ShuntMartin LeonInterventional Cardiovascular CareColumbia University Irving Medical CenterSenior Vice PresidentChief Medical OfficerAdded George FazioCorvia MedicalBreakthrough DeviceThird Rock VenturesGeneral Catalyst PartnersLumira Ventures